Trade Summary

5 days ago, PARMAR KUSH, serving as Dir at Entrada Therapeutics, Inc. (TRDA), sold 155,255 shares at $6.95 per share, for a total transaction value of $1,078,937.45. Following this transaction, PARMAR KUSH now holds 2,691,337 shares of TRDA.

This sale represents a 5.45% decrease in PARMAR KUSH's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, August 6, 2026 and publicly disclosed via SEC Form 4 filing on Monday, August 10, 2026 at 7:54 PM ET, 4 days after the trade was made.

Entrada Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.